Tag Archives: Arcturus Therapeutics

Analysts’ View: Range Resources (RRC), Arcturus Therapeutics (ARCT), First BanCorp (FBP)

Brokerage Firm B. Riley FBR upgraded Range Resources Corporation (NYSE:RRC) shares from Neutral to Buy rating while increasing their price target from $17 to $22.

Range Resources Corporation operates as an independent natural gas, natural gas liquids, and oil company.


Arcturus Therapeutics Ltd. (NASDAQ:ARCT) shares were upgraded by analysts at WBB Securities from Buy to Strong Buy rating.

Arcturus Therapeutics Ltd., an RNA medicines company, develops nucleic acid medicines to treat diseases with unmet medical needs.


Investment Analysts at BofA/Merrill upgraded First BanCorp (NYSE:FBP) shares from Neutral to Buy rating.

First BanCorp. operates as a bank holding company for FirstBank Puerto Rico that provides a range of financial products and services to retail, commercial, and institutional clients.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/